Updated Jul 16, 2026
Clark Eliana is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $106K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-03 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale | 607 | $13.78 | $8K |
| 2026-03-03 | NTLA | Intellia Therapeutics, Inc. | A — Grant or award | 7.4K | $0.00 | |
| 2026-01-07 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale | 9.5K | $9.21 | $88K |
| 2025-07-01 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale | 1.0K | $9.82 | $10K |
Clark Eliana is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($106K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Clark Eliana profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.